Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Arra

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Neuroscience Letters|May 11, 2017
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ<sub>1-42</sub> peptide in a long lasting model of neuropathic painAntimo D'Aniello, Livio Luongo, Rosaria Romano, et al.
Frontiers in Physiology|February 23, 2018
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS ProductionGennaro Riccio, Salvatore Antonucci, Carmela Coppola, et al.
Cancers|April 13, 2023
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant PhenotypeStefano Lucà, Renato Franco, Antonella Napolitano, et al.
Oncotarget|January 18, 2015
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migrationGennaro Chiappetta, Teresa Valentino, Michela Vitiello, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2011
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF proteinGennaro Chiappetta, Anna Basile, Claudio Arra, et al.
Scientific Reports|April 29, 2020
HMGA1-pseudogene7 transgenic mice develop B cell lymphomasMarco De Martino, Davide De Biase, Floriana Forzati, et al.
Plos One|September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesLuigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Biology Open|September 6, 2014
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiationFloriana Forzati, Antonella Federico, Pierlorenzo Pallante, et al.
Oncotarget|June 21, 2016
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cellsVincenzo Ingangi, Katia Bifulco, Ali Munaim Yousif, et al.
Oncotarget|September 24, 2017
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtypeElia Guadagno, Michela Vitiello, Paola Francesca, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Neuroscience Letters|May 11, 2017
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ<sub>1-42</sub> peptide in a long lasting model of neuropathic painAntimo D'Aniello, Livio Luongo, Rosaria Romano, et al.
Frontiers in Physiology|February 23, 2018
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS ProductionGennaro Riccio, Salvatore Antonucci, Carmela Coppola, et al.
Cancers|April 13, 2023
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant PhenotypeStefano Lucà, Renato Franco, Antonella Napolitano, et al.
Oncotarget|January 18, 2015
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migrationGennaro Chiappetta, Teresa Valentino, Michela Vitiello, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2011
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF proteinGennaro Chiappetta, Anna Basile, Claudio Arra, et al.
Scientific Reports|April 29, 2020
HMGA1-pseudogene7 transgenic mice develop B cell lymphomasMarco De Martino, Davide De Biase, Floriana Forzati, et al.
Plos One|September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesLuigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Biology Open|September 6, 2014
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiationFloriana Forzati, Antonella Federico, Pierlorenzo Pallante, et al.
Oncotarget|June 21, 2016
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cellsVincenzo Ingangi, Katia Bifulco, Ali Munaim Yousif, et al.
Oncotarget|September 24, 2017
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtypeElia Guadagno, Michela Vitiello, Paola Francesca, et al.
Pageof 15